Delcath Systems DCTH
Delcath Systems Q2 FY24: revenue $7.8M; diluted EPS −$0.48
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001628280-24-034769
Key figures from this report
These are the numbers Delcath Systems reported for Q2 FY24, the quarter ended Jun 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$7.8MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Net income−$13.7MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS−$0.48No year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$14.8MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
- Cash from operations−$4.5MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Ceribell CBLL public float $417M, Jun 30, 2025
- Axogen AXGN public float $431M, Jun 30, 2025
- Angiodynamics ANGO public float $436M, Nov 30, 2025
- Orthofix Medical OFIX public float $440M, Jun 30, 2025
- Pulse Biosciences PLSE public float $394M, Jun 30, 2025
